Nifekalant

DB16008InvestigationalSmall molecule

Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).

Chemical structure of Nifekalant
Mechanism
Curator reviewed
Formula / weight
C19H27N5O5 · 405.455 g/mol (avg)

Resolves to

Compound
UNII5VZ7GZM43ECAS130636-43-0ChEMBLCHEMBL360861ChEBI94575
Structure
InChIKeyOEBPANQZQGQPHF-UHFFFAOYSA-NSMILESCN1C(=O)C=C(NCCN(CCO)CCCC2=CC=C(C=C2)[N+]([O-])=O)N(C)C1=O
Targets
Q12809KCNH2

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Nifekalant, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In